HCFA Conditional Coverage of PTA Is Stroke of Luck For Carotid Stent Trials
This article was originally published in The Gray Sheet
Executive Summary
The Health Care Financing Administration's national coverage of percutaneous transluminal angioplasty (PTA) under Medicare could help speed up enrollment in the CREST trial.
You may also be interested in...
Boston Scientific Carotid Stent 2004 Launch Will Court Vascular Surgeons
Boston Scientific will complete enrollment of its 775-patient U.S. pivotal carotid stent trial by year-end
Boston Scientific Carotid Stent 2004 Launch Will Court Vascular Surgeons
Boston Scientific will complete enrollment of its 775-patient U.S. pivotal carotid stent trial by year-end
HCFA Proposes Faster And Broader Coverage For Carotid Stent Trials
The Health Care Financing Administration's proposed coverage policy change for carotid artery stenting would be the first national coverage policy requiring local carriers to cover all trials of a specific Category B device type.